BSGM had an interesting day yesterday. Let's start from the beginning...

StockWireNews

Your Thursday Update On Nasdaq Profile (BSGM)

$13.00 Laidlaw & Company Price Target

July 1st

Good Morning,

BSGM had an interesting day yesterday. Let's start from the beginning...

Just after the opening bell, BSGM dropped this press release:

BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology

  • The Company recently increased its procedural volume targets due to accelerated technology usage
  • BioSig expands its commercial team to target technology adoption across three strategic regions

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that physicians have completed 1000 patient cases with its technology across nine installation sites.

Read the full article here.

As this press release continues to make the rounds in the days ahead, it could draw some serious attention from parties that don't know how game-changing the PURE EP System product could be.

BSGM Technical Update

Keeping an eye on BSGM during post-market hours, it bounced back over $4.00 which could be a major sign of things to come.

If potential support builds at that level, BSGM could once again try to make a push towards/past its 200-Day Simple Moving Average (SMA) like it did yesterday.

Furthermore, at close yesterday, Barchart was reporting BSGM to be trading over multiple lines of potential support:

  • 20-Day SMA
  • 50-Day SMA
  • 5-Day EMA
  • 13-Day EMA

That's huge after yesterday's pull back. This could mean that strong potential support could be holding at those levels.

If that's the case, BSGM might try to make a move back towards yesterday's high of $4.58 in the near term.

Additionally, the Barchart website is reporting a "BUY" recommendation for BSGM's composite "TrendSpotter" technical indicator.

Take a minute now before the market is open and read my initial BSGM report below.

-----

*BioSig Technologies, Inc. (BSGM)*

BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals.

The Company’s first product, PURE EP(tm) System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.

Here’s Why PURE EP Could Be a Game-Changer

According to XTalks, PURE EP could fill a significant need because:

The electrograms used today can be riddled with noise and artifacts coming from other equipment found in the operating room. Such a procedure can take up to six hours, potentially yielding what is referred to in the industry as a ‘dirty signal’ that’s indiscernible to interpret by many electrophysiologists.” (1)

BioSig's PURE EP was developed to address unmet needs in a large and growing market and deliver technology to improve catheter ablation treatments for arrhythmias, Atrial Fibrillation, and Ventricular Tachycardia.

The system is intended to acquire, digitize, amplify, filter, measure and calculate, display, record and store electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory under the supervision of licensed healthcare practitioners who are responsible for interpreting the data,” as further reported XTalks. (1)

-----

No. 1 Potential Immediate Term Catalyst - Company's Tech To Be Featured At Stanford Retreat

BioSig’s Signal Processing Technology for Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhythmia Technologies Retreat

Westport, CT, June 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company would be presenting during 2021 Stanford Biodesign New Arrhythmia Technologies Retreat, due to take place virtually on July 27, 2021. The Company will present at 2 pm PT.

[...]

Read the full article here.

-----

No. 2 Potential Immediate Term Catalyst - Potential Squeeze On Horizon?

Check out BSGM's 6-month chart below:

image

As you can see, BSGM dropped to a $2.80 low back in May and has slowly been gaining momentum in recent weeks.

Now trading over $4.00 as of close on Tuesday, BSGM is entering an interesting area on its chart. Let me break it down.

At this moment (closing bell on 6/29), BSGM is trading above 2 key lines of potential support in its:

  • 13-Day Exponential Moving Average (EMA)
  • 50-Day Simple Moving Average (SMA)

With a 200-Day SMA that is being reported by Barchart as $4.41 at close on Tuesday, BSGM could be entering squeeze territory.

If potential resistance breaks down at that level today or in the near future, BSGM could start drawing a ton of interest as a profile trading above 3 key lines (13-Day EMA, 50-Day SMA, 200-Day SMA).

This is why you need to pay attention to this tidbit of info...

No. 3 Potential Immediate Term Catalyst - Low Float

According to Yahoo Finance, BSGM has a small float.

The website reports this profile to have 27.69Mn shares in its float.

Why is that important? It's important on one crucial level. Volatility.

With so few shares available for trading, potential catalysts can send shares heading vertical in the short-term.

-----

No. 4 Potential Immediate Term Catalyst - Strong Analyst Coverage, Big Target

Last year, Laidlaw & Company provided BSGM with a $13.00 target.

From Tuesday's close, this gives BSMG over 200% potential upside.

Here's the major highlight from the report:

  • Major value driver, the PURE EP system is a first-to-market and novel signal processing system that could help to improve the efficacy of catheter ablation in arrhythmia patients. The key value proposition of the PURE EP system is to provide electrophysiologists with visualized original and less distorted cardiac signals after the removal of most of the noise and artifacts. This enables them more precisely to identify and destroy the diseased sites during the catheter ablation procedure and improve the success rate in treating atrial fibrillation (AFib) and ventricular tachycardia (VT). The use of the PURE EP system could potentially lead to more procedures being performed and translate to more hospital revenue. The PURE EP system was approved [510(k) clearance] in 3Q18. BSGM is conducting a randomized and blinded post-marketing clinical study to potentially demonstrate an improved signal by the PURE EP system vs. the current SOC recording/mapping system. A portion (n=34) of the outcome would be submitted for a publication, likely in 2020. With potential competitors far behind, the PURE EP system is likely to be the leading player in this space

-----

No. 5 Potential Immediate Term Catalyst - 2 Key MedTech Sales Executives Join The Team

BioSig Expands Commercial Team in Two Strategic Regions

Westport, CT, April 15, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it added two experienced electrophysiology Regional Directors to lead commercial expansion across Southeast and Central regions.

[...]

Read the full article here.

-----

Nasdaq (BSGM) Recap: Potential Immediate Term Catalysts To Know Right Now

#1. Company's Tech To Be Featured At Stanford Retreat

#2. Potential Squeeze On Horizon?

#3. Low Float

#4. Strong Analyst Coverage, Big Target

#5. 2 Key MedTech Sales Executives Join The Team

-----

Coverage is officially initiated on BSGM. When you have time later, do this:

image

If there are any more updates today, I'll get them out to you quickly.

Sincerely,

Kai Parker

StockWireNews


Source 1


(Always Remember The Stock Prices Could Be Significantly Lower Now From The Dates I Provided.)

Disclosure: I am not a lice.nsed finan.cial adviser. All potential percentage gains are based on from the low to the high of day. StockWireNews full disclosure is to be read and fully understood before using StockWireNews website, or joining StockWireNews' email or text list. By viewing StockWireNews website and/or reading Stock Wire News email or text newsletter you are agreeing to StockWireNews full disclosure which can be read at www.stockwirenews.net/disclosure StockWireNews (stockwirenews . com) is owned by StockNewsWire LLC, a limited liability company. An owner of StockNewsWire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com (“SCF”), an interest in the limited liability company that owns and operates fierceinvestor . com (“FI”), an interest in the limited liability company that owns and operates stockstreetwire . com (SSW), and an interest in the limited liability company that owns and operates nasdaq wire news . com (NWN) . From time to time, StockWireNews, SCF, FI, SSW, and/or NWN will publicly disseminate information about a company via website, email, SMS and other points of media. Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 2/19/20 to publicly disseminate information about (BSGM) via Website, Email and SMS. We have been paid twenty-five thousand USD via bank wire transfer. We own zero shares of (BSGM). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been paid an additional five thousand USD via bank wire transfer on 2/21/20 for continuing coverage of (BSGM). We own zero shares of (BSGM). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 4/9/20 to publicly disseminate information about (BSGM) via Website, Email and SMS. We have been paid seven thousand USD via bank wire transfer. We own zero shares of (BSGM). Pursuant to an agreement between StockNewsWire, LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 6/17/20 to publicly disseminate information about (BSGM) via Website, Email and SMS. We have been paid twenty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (BSGM). Pursuant to an agreement between StockNewsWire, LLC and Legends Media, LLC, StockWireNews has been hired for a one day period on 1/13/21 to publicly disseminate information about (BSGM) via Website, Email and SMS. We have been paid twenty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (BSGM). Pursuant to an agreement between StockNewsWire, LLC and Legends Media, LLC, StockWireNews has been hired for a period beginning on 6/30/21 and ending on 7/1/21 to publicly disseminate information about (BSGM) via Website, Email and SMS. We have been paid twenty-six thousand five hundred USD via bank wire transfer. We own zero shares of (BSGM). To date, we have been compensated a total of one hundred and eighteen thousand five hundred USD to disseminate information about (BSGM).